Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-9 of 9
1-9 of 9
Filter
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Mike Sandoval
President at Sante Laboratories
accuracy and precision, analytical chemistry, aspergillosis, bank, bioavailability, brand, breakfast, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemical substance, chemistry, competition, consumer protection, conversation, crystallization, cytochrome p450, diclofenac, dietary supplement, distillation, dose (biochemistry), dream, drug development, due diligence, electronic cigarette, emulsion, endocannabinoid system, experiment, expert, expungement, food and drug administration, frosted mini-wheats, health, human, humidity, ibuprofen, immunodeficiency, infection, information, insurance, investor, laboratory, loan, market (economics), medical cannabis, memory, mold, money, mycotoxin, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, ph meter, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, reason, regulatory compliance, route of administration, safety, scientific method, sesame, shelf life, sleep, solution, stove, tablet (pharmacy), technology, temperature, tetrahydrocannabinol, the matrix, traceability, tractor, transparency and translucency, treaty, understanding
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
William Fisher
Board Chairman at Diverse Biotech
appetite, aspirin, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), chemotherapy, clinical trial, dementia, dietary supplement, direct-to-consumer advertising, dose (biochemistry), drug development, endocannabinoid system, fibromyalgia, first, pass effect, food and drug administration, gastrointestinal tract, headache, hemp, in vitro, inflammation, intravenous therapy, micro-encapsulation, nanoparticle, nutraceutical, opioid epidemic in the united states, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, route of administration, sensitivity and specificity, steve jobs, synthetic cannabinoids, tetrahydrocannabinol, toxicity
1
1-9 of 9